These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29661681)

  • 21. A role for mammalian target of rapamycin in regulating T cell activation versus anergy.
    Zheng Y; Collins SL; Lutz MA; Allen AN; Kole TP; Zarek PE; Powell JD
    J Immunol; 2007 Feb; 178(4):2163-70. PubMed ID: 17277121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity.
    Bayle JH; Grimley JS; Stankunas K; Gestwicki JE; Wandless TJ; Crabtree GR
    Chem Biol; 2006 Jan; 13(1):99-107. PubMed ID: 16426976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iCaspase 9 Suicide Gene System.
    Zhou X; Di Stasi A; Brenner MK
    Methods Mol Biol; 2015; 1317():87-105. PubMed ID: 26072403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
    Oshiro N; Yoshino K; Hidayat S; Tokunaga C; Hara K; Eguchi S; Avruch J; Yonezawa K
    Genes Cells; 2004 Apr; 9(4):359-66. PubMed ID: 15066126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
    Hoyos V; Del Bufalo F; Yagyu S; Ando M; Dotti G; Suzuki M; Bouchier-Hayes L; Alemany R; Brenner MK
    Mol Ther; 2015 Sep; 23(9):1497-506. PubMed ID: 26084970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an inducible suicide gene system based on human caspase 8.
    Carlotti F; Zaldumbide A; Martin P; Boulukos KE; Hoeben RC; Pognonec P
    Cancer Gene Ther; 2005 Jul; 12(7):627-39. PubMed ID: 15746943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saccharomyces cerevisiae FKBP12 binds Arabidopsis thaliana TOR and its expression in plants leads to rapamycin susceptibility.
    Sormani R; Yao L; Menand B; Ennar N; Lecampion C; Meyer C; Robaglia C
    BMC Plant Biol; 2007 Jun; 7():26. PubMed ID: 17543119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-Destruct Genetic Switch to Safeguard iPS Cells.
    Ivics Z
    Mol Ther; 2015 Sep; 23(9):1417-20. PubMed ID: 26321184
    [No Abstract]   [Full Text] [Related]  

  • 29. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
    Serafini M; Bonamino M; Golay J; Introna M
    Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eliminating cells gone astray.
    Sadelain M
    N Engl J Med; 2011 Nov; 365(18):1735-7. PubMed ID: 22047566
    [No Abstract]   [Full Text] [Related]  

  • 31. Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts.
    Cartellieri M; Feldmann A; Koristka S; Arndt C; Loff S; Ehninger A; von Bonin M; Bejestani EP; Ehninger G; Bachmann MP
    Blood Cancer J; 2016 Aug; 6(8):e458. PubMed ID: 27518241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy.
    Philip B; Kokalaki E; Mekkaoui L; Thomas S; Straathof K; Flutter B; Marin V; Marafioti T; Chakraverty R; Linch D; Quezada SA; Peggs KS; Pule M
    Blood; 2014 Aug; 124(8):1277-87. PubMed ID: 24970931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector.
    Pollock R; Issner R; Zoller K; Natesan S; Rivera VM; Clackson T
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13221-6. PubMed ID: 11078518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.
    MacLeod DT; Antony J; Martin AJ; Moser RJ; Hekele A; Wetzel KJ; Brown AE; Triggiano MA; Hux JA; Pham CD; Bartsevich VV; Turner CA; Lape J; Kirkland S; Beard CW; Smith J; Hirsch ML; Nicholson MG; Jantz D; McCreedy B
    Mol Ther; 2017 Apr; 25(4):949-961. PubMed ID: 28237835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α.
    Cao G; Wang Q; Li G; Meng Z; Liu H; Tong J; Huang W; Liu Z; Jia Y; Wei J; Chi H; Yang H; Zhao L; Wu Z; Hao J; Yin Z
    J Leukoc Biol; 2016 Nov; 100(5):1181-1189. PubMed ID: 27256566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies.
    Roellecke K; Virts EL; Einholz R; Edson KZ; Altvater B; Rossig C; von Laer D; Scheckenbach K; Wagenmann M; Reinhardt D; Kramm CM; Rettie AE; Wiek C; Hanenberg H
    Gene Ther; 2016 Jul; 23(7):615-26. PubMed ID: 27092941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.
    Shor B; Zhang WG; Toral-Barza L; Lucas J; Abraham RT; Gibbons JJ; Yu K
    Cancer Res; 2008 Apr; 68(8):2934-43. PubMed ID: 18413763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological characterization of purified recombinant mTOR FRB-kinase domain using fluorescence-based assays.
    Reichling LJ; Lebakken CS; Riddle SM; Vedvik KL; Robers MB; Kopp LM; Bruinsma R; Vogel KW
    J Biomol Screen; 2008 Mar; 13(3):238-44. PubMed ID: 18354135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T cells.
    Cheadle EJ; Hawkins RE; Batha H; O'Neill AL; Dovedi SJ; Gilham DE
    J Immunol; 2010 Feb; 184(4):1885-96. PubMed ID: 20089697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy.
    Sato T; Neschadim A; Konrad M; Fowler DH; Lavie A; Medin JA
    Mol Ther; 2007 May; 15(5):962-70. PubMed ID: 17375075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.